These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30644585)

  • 21. Bridging with glycoprotein IIb/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents.
    Ben Morrison T; Horst BM; Brown MJ; Bell MR; Daniels PR
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):575-82. PubMed ID: 22448399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Use of Cangrelor With Heparin During Cardiopulmonary Bypass in Patients With Heparin-Induced Thrombocytopenia Who Require Cardiovascular Surgery: A Case Series.
    Gernhofer YK; Banks DA; Golts E; Pretorius V
    Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):763-769. PubMed ID: 31610233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cangrelor in patients undergoing cardiac surgery: the BRIDGE study.
    Voeltz MD; Manoukian SV
    Expert Rev Cardiovasc Ther; 2013 Jul; 11(7):811-6. PubMed ID: 23895024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes with cangrelor versus clopidogrel on a background of bivalirudin: insights from the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI]).
    White HD; Bhatt DL; Gibson CM; Hamm CW; Mahaffey KW; Price MJ; Steg PG; Stone GW; Cortese B; Wilensky M; Deliargyris EN; Liu T; Prats J; Harrington RA
    JACC Cardiovasc Interv; 2015 Mar; 8(3):424-433. PubMed ID: 25703887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative cangrelor in patients with recent percutaneous coronary intervention undergoing liver transplantation: A case series.
    Succar L; Lopez CN; Victor DW; Lindberg SA; Saharia A; Sheth S; Mobley CM
    Pharmacotherapy; 2022 Mar; 42(3):263-267. PubMed ID: 35075688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cangrelor Bridge Therapy for Gastroduodenal Biopsy.
    Cahoon WD; Oswalt AK; Francis KE; Magee LC; Lowe DK
    J Pharm Pract; 2017 Apr; 30(2):270-273. PubMed ID: 27000137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of cangrelor in a complex vascular patient: A case report.
    Presley L
    J Vasc Nurs; 2024 Jun; 42(2):138-140. PubMed ID: 38823974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).
    Groves EM; Bhatt DL; Steg PG; Deliargyris EN; Stone GW; Gibson CM; Hamm CW; Mahaffey KW; White HD; Angiolillo DJ; Prats J; Harrington RA; Price MJ
    Circ Cardiovasc Interv; 2018 Apr; 11(4):e005635. PubMed ID: 29632238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cangrelor: a novel P2Y12 receptor antagonist.
    Norgard NB
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1219-30. PubMed ID: 19604122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing the Use of Cangrelor in the Real World.
    Qamar A; Bhatt DL
    Am J Cardiovasc Drugs; 2017 Feb; 17(1):5-16. PubMed ID: 27677505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of data on cangrelor.
    Qamar A; Bhatt DL
    Pharmacol Ther; 2016 Mar; 159():102-9. PubMed ID: 26802900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Safety Evaluation of Cangrelor in Patients Undergoing PCI.
    Franchi F; Rollini F; Park Y; Angiolillo DJ
    Expert Opin Drug Saf; 2016; 15(2):275-85. PubMed ID: 26680584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dual platelet aggregation inhibition in coronary artery stent implantation--what is evidence-based?].
    Baer FM; Erdmann E
    Dtsch Med Wochenschr; 2007 Jun; 132(23):1275-80. PubMed ID: 17541871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Cangrelor as Bridging Therapy Post PCI.
    Khan AA; Murtaza G; Khalid M; Finniss M; Helton T
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(3):227-231. PubMed ID: 32108005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Intravenous Cangrelor as Antiplatelet Bridge Therapy in a Patient Undergoing Esophageal Dilation Procedure.
    Choxi R; Pillai A; Ahmed S; Jovin IS
    Cardiovasc Revasc Med; 2020 Nov; 21(11S):94-95. PubMed ID: 31932170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials.
    Vaduganathan M; Harrington RA; Stone GW; Deliargyris EN; Steg PG; Gibson CM; Hamm CW; Price MJ; Menozzi A; Prats J; Elkin S; Mahaffey KW; White HD; Bhatt DL
    JAMA Cardiol; 2017 Feb; 2(2):127-135. PubMed ID: 27902833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
    Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL;
    JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial.
    Greenbaum AB; Ohman EM; Gibson CM; Borzak S; Stebbins AL; Lu M; Le May MR; Stankowski JE; Emanuelsson H; Weaver WD
    Am Heart J; 2007 Oct; 154(4):702-9. PubMed ID: 17892995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unplanned surgery after drug eluting stent implantation: a strategy for safe temporary withdrawal of dual oral antiplatelet therapy.
    D'Urbano M; Barlocco F; Poli A; Fetiveau R; Vandoni P; Savonitto S; De Servi S
    J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):737-41. PubMed ID: 18545078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bridge with intravenous antiplatelet therapy during temporary withdrawal of oral agents for surgical procedures: a systematic review.
    Morici N; Moja L; Rosato V; Sacco A; Mafrici A; Klugmann S; D'Urbano M; La Vecchia C; De Servi S; Savonitto S
    Intern Emerg Med; 2014 Mar; 9(2):225-35. PubMed ID: 24419741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.